Mesoblast (MESO) Return on Capital Employed [ROCE] (2016 - 2023)
Mesoblast (MESO) recorded Return on Capital Employed [ROCE] of 37.04% in the year ended Jun 30, 2026, up 23.23 percentage points from 13.81% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Return on Capital Employed [ROCE] (2016 - 2023) Analysis & Trends
Starting with the year ended Jun 30, 2015, Mesoblast's Return on Capital Employed [ROCE] history includes 12 years.
- Annual Return on Capital Employed [ROCE] has a five-year change of +54.15 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 is the highest annual Return on Capital Employed [ROCE] in data going back to the year ended Jun 30, 2015.
- Per Business Quant data, MESO's Return on Capital Employed [ROCE] was 13.81% in the year ended Jun 30, 2025 (+1.96 pp), 11.84% in the year ended Jun 30, 2024 (-2.23 pp), 14.07% in the year ended Jun 30, 2023 (+30.77 pp) and -16.70% in the year ended Jun 30, 2022 (+0.41 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Mesoblast | 1.82 Bn | 1.39 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -21.61% |
| Mar 31, 2023 | -21.07% |
| Dec 31, 2022 | -20.78% |
| Sep 30, 2022 | -20.79% |
| Jun 30, 2022 | -21.72% |
| Mar 31, 2022 | -16.96% |
| Dec 31, 2021 | -17.29% |
| Sep 30, 2021 | -16.95% |
| Jun 30, 2021 | -16.69% |
| Mar 31, 2021 | -19.88% |
| Dec 31, 2020 | -18.99% |
| Sep 30, 2020 | -18.63% |
| Jun 30, 2020 | -16.58% |
| Mar 31, 2020 | -14.67% |
| Dec 31, 2019 | -16.39% |
| Sep 30, 2019 | -16.83% |
| Jun 30, 2019 | -17.77% |
| Mar 31, 2019 | -16.63% |
| Dec 31, 2018 | -15.44% |
| Sep 30, 2018 | -12.18% |
API Access
Mesoblast Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();